A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis1

Autor:	Ronald Pruitt, David Sales, George Koval, John K Bell, Dennis Riff, Lawrence Wruble, Lorin K Johnson, Douglas S. Levine
Rok vydání:	2002
Předmět:	medicine.medical_specialty Randomization Hepatology business.industry Gastroenterology Balsalazide medicine.disease Ulcerative colitis law.invention Double blind chemistry.chemical_compound chemistry Randomized controlled trial Mesalazine law Internal medicine medicine Mesalazina Colitis business
Zdroj:	The American Journal of Gastroenterology. 97:1398-1407
ISSN:	1572-0241 0002-9270
Popis:	A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::a6fb948cfb467d603fc5f4effdda4a57 https://doi.org/10.1111/j.1572-0241.2002.05781.x Zobrazit plný text záznamu